Molecule Details
| InChIKey | JHTLAAWJQMVUGR-AIBWNMTMSA-N |
|---|---|
| Compound Name | (2S)-2-[(2-cyclohexylacetyl)amino]-4-methyl-N-(3-methyl-4-oxo-5H-2,3-benzodiazepin-5-yl)pentanamide |
| Canonical SMILES | CC(C)C[C@H](NC(=O)CC1CCCCC1)C(=O)NC1C(=O)N(C)N=Cc2ccccc21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 6 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.85 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (6)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P49768 | PSEN1 | Homo sapiens | Human | PF01080 | 7.8 | IC50 | ChEMBL;BindingDB |
| P49810 | PSEN2 | Homo sapiens | Human | PF01080 | 7.8 | IC50 | ChEMBL |
| Q8WW43 | APH1B | Homo sapiens | Human | PF06105 | 7.8 | IC50 | ChEMBL |
| Q92542 | NCSTN | Homo sapiens | Human | PF18266 PF05450 | 7.8 | IC50 | ChEMBL |
| Q96BI3 | APH1A | Homo sapiens | Human | PF06105 | 7.8 | IC50 | ChEMBL |
| Q9NZ42 | PSENEN | Homo sapiens | Human | PF10251 | 7.8 | IC50 | ChEMBL |